A system and method for determining a treatment to be applied to the brain
The fMRI connectome targeting localization method addresses the variability in brain stimulation by using multi-resolution parcellations and a threshold-free tree-based search to determine individualized stimulation locations and strengths, enhancing treatment efficacy and reliability.
Patent Information
- Application Number
- AU2025212490
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-26
- Filing Date
- 2025-01-27
- Publication Date
- 2026-07-16
AI Technical Summary
Existing brain stimulation techniques face challenges in accurately determining optimal stimulation locations and strengths due to inter-individual variability, leading to potential adverse effects and discomfort, as they often rely on coarse-scale individualized brain networks or one-spot-fits-all anatomical approaches that do not account for anatomical and functional differences among patients.
A novel functional Magnetic Resonance Imaging (fMRI) connectome targeting localization approach that uses multi-resolution parcellations and a threshold-free tree-based search to identify individualized stimulation locations and strengths, considering both functional and anatomical metrics, thereby eliminating the need for manual threshold selection.
This approach significantly improves treatment efficacy and reliability by precisely targeting brain regions, reducing the risk of adverse effects and patient discomfort, while allowing for faster and more reliable dosage titration without the need for manual parameter tuning.